Northwestern Mutual Wealth Management’s Definium Therapeutics DFTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.93K Sell
155
-30
-16% -$509 ﹤0.01% 3491
2025
Q4
$2.48K Buy
185
+19
+11% +$235 ﹤0.01% 3426
2025
Q3
$1.96K Sell
166
-467
-74% -$4.36K ﹤0.01% 3397
2025
Q2
$4.11K Buy
633
+533
+533% +$3.5K ﹤0.01% 3067
2025
Q1
$585 Sell
100
-368
-79% -$2.64K ﹤0.01% 3352
2024
Q4
$3.26K Buy
468
+69
+17% +$475 ﹤0.01% 3068
2024
Q3
$2.27K Buy
399
+14
+4% +$97 ﹤0.01% 3090
2024
Q2
$2.78K Buy
385
+17
+5% +$149 ﹤0.01% 3021
2024
Q1
$3.46K Buy
368
+352
+2,200% +$2.01K ﹤0.01% 2948
2023
Q4
$59 Buy
+16
New +$48 ﹤0.01% 3400
2023
Q3
Sell
-33
Closed -$118 3447
2023
Q2
$118 Sell
33
-33
-50% -$114 ﹤0.01% 3262
2023
Q1
$209 Buy
66
+44
+200% +$146 ﹤0.01% 3182
2022
Q4
$48 Sell
22
-644
-97% -$1.79K ﹤0.01% 3251
2022
Q3
$2K Buy
666
+604
+974% +$5.8K ﹤0.01% 2886
2022
Q2
$1K Buy
+62
New +$784 ﹤0.01% 3048
2021
Q4
Sell
-48
Closed -$2K 3255
2021
Q3
$2K Buy
+48
New +$2.08K ﹤0.01% 2860

Other funds holding DFTX

Northwestern Mutual Wealth Management's DFTX Position: Q1 2026 in Review

Northwestern Mutual Wealth Management reduced its Definium Therapeutics (DFTX) stake by 16% in Q1 2026, selling an estimated $509 and leaving 155 shares worth $2.93K. The position accounts for ﹤0.01% of the portfolio, ranked #3491.

Northwestern Mutual Wealth Management first reported a position in DFTX in Q3 2021 and has held it in 16 quarters since. The position peaked at $4.11K in Q2 2025. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • Northwestern Mutual Wealth Management held 155 shares of Definium Therapeutics worth $2.93K as of Q1 2026.
  • Northwestern Mutual Wealth Management sold 30 Definium Therapeutics shares in Q1 2026, an estimated $509.
  • Definium Therapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #3491 holding.
  • Northwestern Mutual Wealth Management first reported a position in Definium Therapeutics in Q3 2021 and has held it in 16 quarters since.
  • Northwestern Mutual Wealth Management's Definium Therapeutics position peaked at $4.11K in Q2 2025.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.